Literature DB >> 36178570

Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [18F]FDG PET study.

Jing Liu1, Jun Yu1, Hong Biao Liu1, Qiong Yao1, Ying Zhang2.   

Abstract

BACKGROUND: Recent studies suggest that selective serotonin reuptake inhibitors (SSRIs) and exposure therapies have been used to reduced footshock-induced posttraumatic stress disorder (PTSD) symptoms. However, the therapeutic effect of the combination of SSRIs treatment with exposure therapy remains a matter of debate. This study aimed to evaluate these therapeutic effect through the behavioural and the neuroimaging changes by positron emission tomography (PET) in model rats.
METHODS: Pavlovian fear conditioning paradigm to establish model rats, and serial PET imaging with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) was performed during the control, fear-conditioning, and extinction-retrieval phases. The expression of c-Fos was used to identify neural activity.
RESULTS: We report that fear conditioning increased glucose metabolism in the right amygdala and left primary visual cortex but decreased glucose metabolism in the left primary somatosensory cortex. After extinction retrieval, there was increased [18F]FDG uptake in the left striatum, left cochlear nucleus and right primary visual cortex but decreased uptake in the anterior cingulate cortex in the extinction group. Fluoxetine increased [18F]FDG uptake in the left hippocampus and right primary visual cortex but decreased uptake in the bilateral primary somatosensory cortex, left primary/secondary motor cortex and cuneiform nucleus. The combined therapy increased [18F]FDG uptake in the left hippocampus, left striatum, right insular cortex, left posterior parietal cortex, and right secondary visual cortex but reduced uptake in the cerebellar lobule. c-Fos expression in the hippocampal dentate gyrus and anterior cingulate cortex in the fluoxetine and combined groups was significantly higher than that in the extinction group, with no significant difference between the two groups.
CONCLUSIONS: Chronic fluoxetine enhanced the effects of extinction training in a rat model of PTSD. In vivo PET imaging may provide a promising approach for evaluation chronic fluoxetine treatment of PTSD.
© 2022. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.

Entities:  

Keywords:  2-Deoxy-2-[18F]fluoro-D-glucose; Fluoxetine; Hippocampus; Positron emission tomography; Posttraumatic stress disorder

Year:  2022        PMID: 36178570     DOI: 10.1007/s12149-022-01790-0

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.258


  49 in total

Review 1.  Neuronal signalling of fear memory.

Authors:  Stephen Maren; Gregory J Quirk
Journal:  Nat Rev Neurosci       Date:  2004-11       Impact factor: 34.870

Review 2.  Molecular mechanisms of fear learning and memory.

Authors:  Joshua P Johansen; Christopher K Cain; Linnaea E Ostroff; Joseph E LeDoux
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

3.  Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis.

Authors:  Andrea Cipriani; Taryn Williams; Adriani Nikolakopoulou; Georgia Salanti; Anna Chaimani; Jonathan Ipser; Phil J Cowen; John R Geddes; Dan J Stein
Journal:  Psychol Med       Date:  2017-12-19       Impact factor: 7.723

4.  The International Society for Traumatic Stress Studies New Guidelines for the Prevention and Treatment of Posttraumatic Stress Disorder: Methodology and Development Process.

Authors:  Jonathan I Bisson; Lucy Berliner; Marylene Cloitre; David Forbes; Tine K Jensen; Catrin Lewis; Candice M Monson; Miranda Olff; Stephen Pilling; David S Riggs; Neil P Roberts; Francine Shapiro
Journal:  J Trauma Stress       Date:  2019-07-08

5.  Fear erasure in mice requires synergy between antidepressant drugs and extinction training.

Authors:  Nina N Karpova; Anouchka Pickenhagen; Jesse Lindholm; Ettore Tiraboschi; Natalia Kulesskaya; Arna Agústsdóttir; Hanna Antila; Dina Popova; Yumiko Akamine; Amine Bahi; Regina Sullivan; René Hen; Liam J Drew; Eero Castrén
Journal:  Science       Date:  2011-12-23       Impact factor: 47.728

6.  Brain activation to facial expressions in youth with PTSD symptoms.

Authors:  Amy S Garrett; Victor Carrion; Hilit Kletter; Asya Karchemskiy; Carl F Weems; Allan Reiss
Journal:  Depress Anxiety       Date:  2012-05       Impact factor: 6.505

7.  Posttraumatic stress disorder in the World Mental Health Surveys.

Authors:  K C Koenen; A Ratanatharathorn; L Ng; K A McLaughlin; E J Bromet; D J Stein; E G Karam; A Meron Ruscio; C Benjet; K Scott; L Atwoli; M Petukhova; C C W Lim; S Aguilar-Gaxiola; A Al-Hamzawi; J Alonso; B Bunting; M Ciutan; G de Girolamo; L Degenhardt; O Gureje; J M Haro; Y Huang; N Kawakami; S Lee; F Navarro-Mateu; B-E Pennell; M Piazza; N Sampson; M Ten Have; Y Torres; M C Viana; D Williams; M Xavier; R C Kessler
Journal:  Psychol Med       Date:  2017-04-07       Impact factor: 7.723

Review 8.  Implications of memory modulation for post-traumatic stress and fear disorders.

Authors:  Ryan G Parsons; Kerry J Ressler
Journal:  Nat Neurosci       Date:  2013-01-28       Impact factor: 24.884

9.  PET imaging reveals brain functional changes in internet gaming disorder.

Authors:  Mei Tian; Qiaozhen Chen; Ying Zhang; Fenglei Du; Haifeng Hou; Fangfang Chao; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-16       Impact factor: 9.236

10.  Chronic fluoxetine prevents fear memory generalization and enhances subsequent extinction by remodeling hippocampal dendritic spines and slowing down systems consolidation.

Authors:  Lizeth K Pedraza; Rodrigo O Sierra; Marcelo Giachero; Walquiria Nunes-Souza; Fernanda N Lotz; Lucas de Oliveira Alvares
Journal:  Transl Psychiatry       Date:  2019-01-31       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.